Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy
Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy
This observational study aims to investigate how VIMPAT® is used as adjunctive therapy in
 clinical practice and will also evaluate the subsequent change in the drug load of patients
 after addition of VIMPAT® to their treatment regimen.
Inclusion Criteria:

 -  The patient has not received Vimpat® more than 7 days prior to start of
 Non-Interventional Study (NIS)

 -  The patient must have a diagnosis of epilepsy with partial-onset seizures with or
 without secondary generalization

 -  Based on the physician's clinical judgment, it is in the patient's best interest to be
 prescribed adjunctive Vimpat® (ie, the decision to prescribe Vimpat® is made by the
 physician)

 -  Patient must be at least 18 years of age

 -  The patient must have had at least one seizure within the last 3 months prior to
 enrolment